Squawk on the Street

CNBC
undefined
Jan 16, 2026 • 2min

Cramer’s Morning Take: GE Vernova 1/16/26

Listen in as Jim Cramer highlights GE Vernova as a standout energy tech company that deserves a significant rating boost. He discusses the potential for data center operators to drive investment through long-term contracts, indicating a promising market shift. Tune in for insider insights and predictions that could shape your investing strategies!
undefined
11 snips
Jan 16, 2026 • 47min

SOTS 2nd Hour: Software Slump, & Washington's Affordability Push - Energy & The Autos w/Transportation Sec. Duffy 1/16/26

Transportation Secretary Sean Duffy, a former congressman leading auto affordability initiatives, discusses plans to lower vehicle costs by rolling back CAFE standards and introducing tax credits for American-made cars. Adam Parker, Founder of Trivariate Research, analyzes the negative sentiment in the software sector, highlighting bearish trends and the need for increased capital expenditures. The conversation also touches on the White House's push for tech-fueled energy solutions and the impact of EV regulations on consumer choice.
undefined
18 snips
Jan 16, 2026 • 45min

Chips Extend Rally, Micron CEO "First on CNBC," Five More Years for Dimon?  1/16/26

Sanjay Mehrotra, CEO and Chairman of Micron Technology, discusses the booming chip sector, highlighting a $250 billion U.S.-Taiwan trade deal for chip manufacturing. He shares insights on breaking ground for a new chipmaking complex in New York and Micron's technology leadership in DRAM and NAND. The conversation also touches on an expected supply crunch extending into 2027. Additionally, the podcast delves into Jamie Dimon's remarks about his desire to stay at JPMorgan for 'at least' five more years and the potential implications of this statement.
undefined
4 snips
Jan 15, 2026 • 3min

Cramer’s Morning Take: BlackRock 1/15/26

BlackRock's earnings beat and impressive 12% growth in base fees highlight its financial strength. Jim Cramer dives into Larry Fink's bullish outlook and a notable 10% dividend boost. With $342 billion in quarterly inflows, the firm's assets exceeded $14 trillion. Cramer discusses strategic acquisitions and the competitive edge BlackRock holds in tech and global reach. Despite recent stock declines, he argues that it's still a buyable opportunity, emphasizing its resilience and infrastructure capabilities.
undefined
11 snips
Jan 15, 2026 • 43min

SOTS 2nd Hour: Semis Surge, Fmr. Treasury Secretary Lew & The Big Banks Breakdown: Day 2 1/15/26

Jack Lew, former U.S. Treasury Secretary and Columbia University professor, offers critical insights into the DOJ investigation into Fed Chair Powell, emphasizing the importance of Fed independence for economic stability. He discusses the potential risks of politicizing the Fed, warning it could undermine credibility. The conversation also touches on U.S.-Iran tensions, with Lew analyzing the resilience of Iran's regime amid protests and the implications of recent Treasury sanctions aimed at the country's shadow banking system.
undefined
20 snips
Jan 15, 2026 • 45min

Tech Rebounds on Taiwan Semi/AI Trade, BlackRock CEO Larry Fink Exclusive, Big Bank Earnings Wrap-up 1/15/26

Larry Fink, the Chairman and CEO of BlackRock, shares insights into the firm's impressive $14 trillion in assets and record inflows. He discusses the impact of AI on investing strategies and the importance of democratizing access to financial opportunities. Fink explains how BlackRock leverages technology with its Aladdin platform and explores global investment themes, including opportunities outside the U.S. He also touches on government policies, fiscal discipline, and the necessity for CEOs to engage in global dialogues, especially around issues like Ukraine's reconstruction.
undefined
10 snips
Jan 14, 2026 • 44min

SOTS 2nd Hour: The Big Banks Breakdown, Value Investing Picks, & A Washington Wrap-up 1/14/26

Eamon Javers, a Washington correspondent focused on Supreme Court and tariff issues, discusses the implications of a delayed SCOTUS ruling on major tariffs. Loretta Mester, former Cleveland Fed President, analyzes inflation dynamics and expectations for Federal Reserve policies. Bill Nygren, a seasoned portfolio manager, shares insights on value investing, emphasizing companies like Warner Bros. Discovery and Citi. The podcast also dives into Tesla's switch to a subscription model for Full Self-Driving technology and congressional discussions about banning lawmakers from stock trading.
undefined
8 snips
Jan 14, 2026 • 42min

Bank Earnings Day Two, Trump vs. Powell, "Good News, Bad News" Inflation Picture 1/14/26

Eamon Javers, a Washington-based CNBC reporter, dives into the heated clash between President Trump and Jerome Powell, exploring the implications of a potential DOJ probe into the Fed chair. The discussion shifts to staggering bank earnings results, with significant stock responses from Bank of America and Wells Fargo. Javers also illuminates upcoming Supreme Court decisions on tariffs and their ramifications, while Netflix’s move towards an all-cash deal for Warner Bros adds fuel to the corporate strategy fire.
undefined
Jan 13, 2026 • 44min

SOTS 2nd Hour: More Powell Probe Fallout, CPI Market Impact, & Bank Earnings Breakdown 1/13/26

Julian Emanuel, Senior Managing Director at Evercore ISI, shares insights on market volatility and inflation trends. Former Barclays CEO Bob Diamond discusses bank earnings, praising the current banking environment and the potential for consolidation. They delve into the implications of the DOJ investigation into Fed Chair Powell and its impact on market sentiment. The discussion also touches on the role of AI in enhancing financial services efficiency and the importance of Fed independence amidst ongoing policy risks.
undefined
10 snips
Jan 13, 2026 • 42min

DOJ Powell Probe Backlash, JPMorgan Chase's Earnings Beat, Eli Lilly CEO Exclusive 1/13/26

David Ricks, the CEO of Eli Lilly and Company, joins the conversation to share insights on revolutionizing obesity therapies. He emphasizes the significance of their groundbreaking oral GLP-1s, designed to make treatment more accessible. Ricks discusses the ambitious $50 billion investment in manufacturing to support their expansion and innovative collaborations with NVIDIA to enhance drug discovery. The discussion also touches on the broader therapeutic potential of incretins, showcasing their impact beyond weight loss.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app